Dyne Therapeutics Inc.

NASDAQ: DYN · Real-Time Price · USD
12.26
0.50 (4.25%)
At close: May 29, 2025, 3:59 PM
12.24
-0.16%
After-hours: May 29, 2025, 04:04 PM EDT
4.25%
Bid 11.07
Market Cap 1.39B
Revenue (ttm) n/a
Net Income (ttm) -367.13M
EPS (ttm) -3.61
PE Ratio (ttm) -3.4
Forward PE -3.14
Analyst Buy
Ask 12.43
Volume 1,298,368
Avg. Volume (20D) 2,465,101
Open 12.04
Previous Close 11.76
Day's Range 11.68 - 12.34
52-Week Range 6.36 - 47.45
Beta 1.19

About DYN

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DYN
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for DYN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 weeks ago
+20.21%
Dyne Therapeutics shares are trading higher. The c... Unlock content with Pro Subscription
3 weeks ago
-15.3%
Shares of vaccine and gene therapy stocks are trading lower after FDA Commissioner Marty Makary reportedly named Vinay Prasad as director of the Center for Biologics and Research.